DUBLIN--(BUSINESS WIRE)--The "Global Eye Allergy Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
This is expected to propel the growth of the market during the forecast period. Analysts have predicted that the eye allergy therapeutics market will register a CAGR of almost 5% by 2023.
The global eye allergy therapeutics market is currently witnessing a high unmet medical need for a once-daily double-action eye preparation for the treatment of various types of eye allergies. At present, the drugs administered for eye allergies are intended to treat symptoms such as redness and itching, and they provide substantial assistance to patients leaving approximately 20-30% of the patients untreated.
Also, the side effects associated with the available therapeutic options limit their use for a long duration. Therefore, the market is currently exhibiting a need for effective multiple-dose therapies that can treat the signs and symptoms of eye allergies with a quick onset of action and without side effects.
Market Overview
Significant comorbidity associated with eye allergies
All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients' lives. This leads to loss of work performance decreased productivity and increased healthcare costs, which can put a significant economic burden on patients. To avoid the substantial comorbidity associated with eye allergies, people spend on the required therapeutics, which will drive the growth of the market during the forecast period.
Lack of awareness
The level of awareness about eye allergies is generally low. Media and the Internet were the primary sources of information for most people. The level of knowledge and awareness regarding eye allergies are low among medical students and was far lower among those with a non-medical background. The lack of awareness of the symptoms associated with eye allergies and the negligence in seeking medical help for their treatment are expected to limit the growth of the market during the forecast period.
Competitive Landscape
The market appears to be fragmented. The presence of several companies, including Akorn Inc. and Allergan Plc, the competitive environment is quite intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies. Bausch Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd. are some of the major companies covered in this report.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
Preface
Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: EYE ALLERGY: AN OVERVIEW
PART 07: PIPELINE ANALYSIS
PART 08: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Antihistamines - Market size and forecast 2018-2023
Mast cell stabilizers - Market size and forecast 2018-2023
Corticosteroids - Market size and forecast 2018-2023
Immunomodulators - Market size and forecast 2018-2023
Others - Market size and forecast 2018-2023
Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 15: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
- Akorn Inc.
- Allergan Plc
- Bausch Health Companies Inc.
- Novartis AG
- Santen Pharmaceutical Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/bymuho
